Andrew Keene

Andrew Keene

Andrew Keene was an independent equity options trader on the Chicago Board Options Exchange for 11 years. He spent most of that time as a market maker in over 125 stocks, including Apple, General Electric, Goldman Sachs, and Yahoo. From 2006-2009, Andrew was the biggest, independent on-the-floor Apple trader in the world. Currently, Andrew is actively trading futures, equity options, currency pairs and commodities.

No Comments

Risk Reversal in FIO

Utah-based flash memory manufacturer Fusion-io (NYSE: FIO, $11.32, up $0.10 yesterday) popped 20% in a single day this past September, following Western Digital’s (WDC) acquisition of Virident and investor speculation that FIO could be next.  Shares traded to nearly $16, but pulled back below $10 in November and are now trading at a more modest […]






No Comments

Endeavour Earnings and Europe

Endeavour International Corporation (NYSE: END, $5.12, up $0.26) is an oil and gas company specializing in the exploration, development, and acquisition of energy resources, with operations concentrated in the continental United States and in North Sea area of the United Kingdom. Shortly after 1 PM CST in Monday’s session, we saw a trader come in […]






No Comments

Yes SIR, Buying Calls Sir

Select Income REIT (NYSE: SIR, $29.15, up $0.73) is a real estate investment trust owning 48 properties, including 11 leased land areas in Hawaii and 37 commercial properties across the mainland United States.  SIR stock has generally performed well, and is up 30% from its March 2012 IPO price. Earlier today with SIR trading below […]






No Comments

Call “Stupid” in AVNR

For the second time this week, we see heavy call buying in a pharmaceutical name. Avanir Pharmaceuticals (Nasdaq: AVNR, $3.97, up $0.13) specializes in developing medication for the treatment of neurological disorders including Alzheimer’s and Parkinson’s, and has several products in Phases II and III of FDA testing.






No Comments

Busy Session Kicks Off the Week

After last week’s shortened holiday week, the market is off to a strong start in the first part of Monday’s session.  The SPX traded up over 20 points, with a P/C ratio of around 1.5. We saw a large buyer of Endo Health Solutions (Nasdaq: ENDP, $79) calls.  The Pennsylvania-based pharmaceutical company specializes in the […]






No Comments

Trader Takes a Huge Volatility Position in ELN

Elan Corporation (ELN, $14.45, up $0.35) announced their Q2 earnings this morning and stated a profit that exceeded expectations from Wall Street. The company discussed how their EPS increased to $4.28, which beat analyst estimates by $0.02. Their earnings were largely impacted by the transaction of the blockbuster drug Tysabri, which was a significant portion […]






No Comments

Getting Short PBF

PBF Energy Inc. or (PBF, $22.63, up $0.46) refines petroleum along with supplying transportations fuels, petrochemical feedstocks, heating oils, lubricants and other products within the U.S. PBF Energy is able to make these products in its refineries and then sells their products throughout parts of the United States as well as some regions in Canada. […]






One Comment

Talisman Energy (TLM), Overview and Trade

Talisman Energy, Inc. (NYSE:TLM, $11.30, off $0.07) is a global gas and oil production company headquartered in Calgary, Alberta, Canada. TLM used to be the Canadian portion of British Petroleum but sold 57% of its shares to the public in 1992 and was eventually re-branded as Talisman Energy Inc. It is the largest independent oil […]






No Comments

Trader Takes $780,000 Call Position in the EWJ

iShares MSCI Japan Index (NYSEARCA:EWJ) is an ETF made up of stocks that are primarily traded on the Tokyo Stock Exchange. EWJ tracks the MSCI Japan, which is an index that measures the performance of the Japanese equity market. The ETF has a relatively low volatility with a beta rating of .74 and a dividend […]






No Comments

Trader Gets Short TXRH

Texas Roadhouse Inc (TXRH, $25.31), owns 320 restaurants with an additional 72 that are franchised and or licensed. TXRH has a 52-week range between $15.72-$25.99. On the year the stock is up 48.42% and over a 12-month period TXRH is up 40.16%. The company has grown 46% within the last six months, which is surprising […]